Effects of inflammatory factors including plasma tumor necrosis factor-α in the clinical treatment of acute respiratory distress syndrome

Oncology Letters

Volumn 13, Issue 6, 2017, Pages 5016-5020

  Huang, Shu Ran ^a,b   Ma, Ai Ying ^b   Liu, Yuan ^a   Qu, Yan ^a  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

^b JINING MEDICAL UNIVERSITY   (China)

Author keywords

Acute respiratory distress syndrome; Clinical treatment sequence; Interleukin; Plasma tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLYCERYL TRINITRATE; INTERLEUKIN 6; INTERLEUKIN 8; PROPOFOL; TUMOR NECROSIS FACTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL PARTIAL OXYGEN PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BLOOD GAS PARAMETERS; BLOOD SAMPLING; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OXYGEN THERAPY; OXYGENATION INDEX; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 85019674289     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2017.6090     Document Type: Article

References (22)

1. Komiya K, Ishii H, Murakami J, Yamamoto H, Okada F, Satoh K, Takahashi O, Tobino K, Ichikado K, Johkoh T and Kadota J: Comparison of chest computed tomography features in the acute phase of cardiogenic pulmonary edema and acute respiratory distress syndrome on arrival at the emergency department. J Thorac Imaging 28: 322-328, 2013.
2. Cardinale L, Volpicelli G, Lamorte A and Martino J; Andrea Veltri: Revisiting signs, strengths and weaknesses of standard chest radiography in patients of acute dyspnea in the emergency department. J Thorac Dis 4: 398-407, 2012.
3. Wang HY: The role of cytokines and inflammatory mediators in the pathogenesis of acute respiratory distress syndrome. Chin J Lung Dis: Electron Edit 7: 83-86, 2014.
4. Ma LJ and Li WP: Jin luminescence acute lung injury/acute respiratory distress syndrome: Research progress in the pathogenesis of the disease. Chin J Lung Dis: Electron Edit 6: 65-68, 2013.
5. Tangvarasittichai S, Pongthaisong S and Tangvarasittichai O: Tumor necrosis factor-A, interleukin-6, C-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women. Indian J Clin Biochem 31: 68-74, 2016.
6. Kim S, Yamamoto K, Nakamura Y, Otoyo Y and Yamatodani A: A possible mechanism of cisplatin-induced tumor necrosis factor (TNF)-α production in murine macrophages. Pharmacol Pharm 4: 146-151, 2013.
7. Yan X, Wang XY, Sheng YH, Zhu L, Zhang LD and Zang Q: Exploration of the theory of ‘Fei and Dachang being interior-exteriorly related’ from observing changes of inflammatory cytokines and oxygen free radicals in the lung tissue of ulcerative colitis rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 34: 455-459, 2014 (In Chinese).
8. Wang JL and Hu JL: New progress of respiratory support therapy for treating acute respiratory distress syndrome. J Clin Pulmon Med: 533-536, 2016.
9. Yuan WF, Li L, Li YF, et al: Effects of TNF-α on lung tissue apoptosis in mice with acute lung injury induced by lipopolysaccharide. Int J Respirat 32: 565-568, 2012.
10. Hudord WE, Bigatello LM, Haspel KL, Hess DR and Warren RL (eds): In: Critical care handbook of the massachusetts general hospital. 3rd edition. Shenyang: Liaoning Science and Technology Press: 257-267, 2001.
11. Bein T, Grasso S, Moerer O, Quintel M, Guerin C, Deja M, Brondani A and Mehta S: The standard of care of patients with ARDS: Ventilatory settings and rescue therapies for refractory hypoxemia. Intensive Care Med 42: 699-711, 2016.
12. Liang JY, Jia JF and Peng NG: Clinical analysis of acute respiratory distress syndrome caused by blunt chest trauma. Chin J Tradit Chin Med 02: 139-140, 2010.
13. Huang YZ and Qiu HB: Current situation and challenge of mechanical ventilation strategy for acute respiratory distress syndrome. Intern Med Theory Pract 05: 470-475, 2010.
14. Yang LJ: Serum levels of IL-6, IL-8, TNF-, hs-CRP and lung function in patients with moderate to severe chronic obstructive pulmonary disease. J Clin Pulmon: 481-484, 2016.
15. Scharl M: Pathophysiological role of TNF in inflammatory bowel disease: TNF and its effect on innate immune defense. Front Gastroint Res 34: 49-55, 2015.
16. Sun ZJ, Lu Q and Li YP: Cytokines and inflammatory mediators in acute respiratory distress syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 15: 186-189, 2003 (In Chinese).
17. Roux J, Mcnicholas CM, Carles M, Goolaerts A, Houseman BT, Dickinson DA, Iles KE, Ware LB, Matthay MA and Pittet JF: IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism. FASEB J 27: 1095-1106, 2013.
18. Wang CY, Wu H, Wang W, et al: Significance of PCT, HS-CRP and FIB in the treatment of pulmonary tuberculosis. J Clin Pulmon: 1608-1610, 2015.
19. Yang Q: Acute lung injury and inflammatory mediators. Clin Pulmon Med J 16: 741-743, 2011.
20. Yang T and Lu JX: Experimental study on the protective effect of propofol on severe acute pancreatitis associated lung injury. Zhejiang Depart Traum Surg 17: 312-314, 2012.
21. Wang X, Liu C and Wang G: Propofol protects rats and human alveolar epithelial cells against lipopolysaccharide-induced acute lung injury via inhibiting HMGB1 expression. Inflammation 39: 1004-1016, 2016.
22. Lee BC, Kyoung KH, Kim YH and Hong SK: Non-invasive ventilation for surgical patients with acute respiratory failure. J Korean Surg Soc 80: 390-396, 2011.